Fundraising Fox
/Companies
Sign in

SmartCatch

Portola Valley, US · Delaware corporation · 2 known investors

Find your way into SmartCatch

Sign up to see every warm intro you have to SmartCatch

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the SmartCatch team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Sign up with GoogleAlready have an account? Log in

SmartCatch develops compact microfiltration devices that isolate Circulating Tumor Cells (CTCs) directly from whole blood without pre-analytical steps, enabling liquid biopsy for cancer diagnosis and monitoring. Its products target clinicians, pharmaceutical companies, and researchers in medical oncology and precision medicine.

BiotechDeep TechHealthtechMedical Devices

Founders & leadership

MD
MARK DAHMExecutive

Board

RD
RICHARD DEATLEYBoard director
RT
ROBERT TERRYBoard director
TD
TJ DURNANBoard director

Investors · 2

M Capital Partnerslisted by M Capital PartnersToulouse

How we know: open dataset · 5k.vc investor directory · Not right? Tell us

Reported raises · per SEC filings

Form D private placements

$575.6K disclosed across 1 round · 2017

▶$575.6KraisedMar 2017 · 3 investors · Other Technology
Rule 506(b)
Officers, directors & promoters on the filing
  • RICHARD DEATLEYDirector
  • ROBERT TERRYDirector
  • TJ DURNANDirector
  • MARK DAHMExecutive Officer, Director
Offering amount
$3.7M
Amount sold
$575.6K
First sale
Mar 2017
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Frequently asked questions

What does SmartCatch do?
SmartCatch develops compact microfiltration devices that isolate Circulating Tumor Cells (CTCs) directly from whole blood without pre-analytical steps, enabling liquid biopsy for cancer diagnosis and monitoring. Its products target clinicians, pharmaceutical companies, and researchers in medical oncology and precision medicine.
Who are SmartCatch's investors?
SmartCatch's investors include Kurma Partners, M Capital Partners.
How much funding has SmartCatch raised?
SmartCatch has disclosed $575.6K raised across 1 round.
Where is SmartCatch headquartered?
SmartCatch is headquartered in Portola Valley, US.